Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi.

× No keyword cloud information.

11 in total

1. Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers.

Authors: Carmelo Carlo-Stella; Francesca Ricci; Serena Dalto; Rita Mazza; Michele Malagola; Francesca Patriarca; Simonetta Viviani; Domenico Russo; Laura Giordano; Luca Castagna; Paolo Corradini; Armando Santoro
Journal: Oncologist Date: 2015-02-10

2. Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma.

Authors: J El Cheikh; R Massoud; I Abudalle; B Haffar; R Mahfouz; M A Kharfan-Dabaja; T Jisr; A Mougharbel; A Ibrahim; A Bazarbachi
Journal: Bone Marrow Transplant Date: 2017-04-10 Impact factor: 5.483

3. High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.

Authors: L Castagna; R Crocchiolo; L Giordano; S Bramanti; C Carlo-Stella; B Sarina; A Chiti; E Mauro; S Gandolfi; E Todisco; M Balzarotti; A Anastasia; M Magagnoli; E Brusamolino; A Santoro
Journal: Bone Marrow Transplant Date: 2015-01-26 Impact factor: 5.483

Review 4. Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma.

Authors: Luca Castagna; Carmelo Carlo-Stella; Rita Mazza; Armando Santoro
Journal: Mediterr J Hematol Infect Dis Date: 2015-02-15 Impact factor: 2.576

5. Successful Use of Nivolumab in a Patient with Head and Neck Cancer After Allogeneic Bone Marrow Transplantation.

Authors: Xiaopei Dong; Ning Lu; Zhongsheng Tong; Yehui Shi
Journal: Onco Targets Ther Date: 2021-02-10 Impact factor: 4.147

6. Relapsing/refractory HL after autotransplantation: which treatment?

Authors: Nicola Di Renzo; Francesco Gaudio; Carmelo Carlo Stella; Sara Oppi; Matteo Pelosini; Roberto Sorasio; Caterina Stelitano; Luigi Rigacci
Journal: Acta Biomed Date: 2020-05-25

7. Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma.

Authors: Christopher J Forlenza; Nitya Gulati; Audrey Mauguen; Michael J Absalon; Sharon M Castellino; Anna Franklin; Frank G Keller; Neerav Shukla
Journal: Blood Adv Date: 2021-12-28

Review 8. Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update.

Authors: Bruce D Cheson; Wolfram Brugger; Gandhi Damaj; Martin Dreyling; Brad Kahl; Eva Kimby; Michinori Ogura; Eckhart Weidmann; Clemens-Martin Wendtner; Pier Luigi Zinzani
Journal: Leuk Lymphoma Date: 2015-11-23

Review 9. Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation.

Authors: Eva Domingo-Domènech; Anna Sureda
Journal: J Clin Med Date: 2020-05-08 Impact factor: 4.241

Review 10. Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective.

Authors: Anna Sureda; Marc André; Peter Borchmann; Maria G da Silva; Christian Gisselbrecht; Theodoros P Vassilakopoulos; Pier Luigi Zinzani; Jan Walewski
Journal: BMC Cancer Date: 2020-11-10 Impact factor: 4.430